Dark chocolate intake and cardiovascular diseases: a Mendelian randomization study

Area of Science:

• Cardiovascular Epidemiology
• Nutritional Science
• Genetic Epidemiology

Background:

• Previous studies suggest cardiovascular benefits of dark chocolate.
• The causal relationship between dark chocolate consumption and cardiovascular disease (CVD) risk remains unclear.
• Existing research lacks definitive evidence on dark chocolate's impact on various CVDs.

Purpose of the Study:

• To investigate the causal association between dark chocolate intake and the risk of developing cardiovascular diseases (CVDs).
• To explore the potential protective effects of dark chocolate on specific cardiovascular conditions.
• To provide evidence-based insights for public health strategies related to diet and heart health.

Main Methods:

• A Mendelian randomization (MR) study design was employed.
• Summary-level data from genome-wide association studies (GWAS) on dark chocolate intake and CVDs were utilized.
• Inverse variance weighted (IVW) fixed-effect model and sensitivity analyses were performed to ensure result robustness.

Main Results:

• Dark chocolate intake showed a significant causal association with a reduced risk of essential hypertension (EH).
• A suggestive association was observed between dark chocolate intake and a reduced risk of venous thromboembolism.
• No significant causal associations were found between dark chocolate intake and ten other studied CVDs.

Conclusions:

• This study provides robust evidence for a causal link between dark chocolate consumption and a lower risk of essential hypertension.
• The findings suggest potential benefits of dark chocolate for cardiovascular health, particularly in relation to hypertension prevention.
• Implications for public health include considering dark chocolate as part of dietary strategies for managing and preventing essential hypertension.